XBiotech Inc. - Common Stock – Quartalsfinanzdaten (NASDAQ:XBIT)

Financials

Übersicht Finanzbericht Statistik Dividenden

Mittelzufluss aus laufender Geschäftstätigkeit -6.54 M-6.72 M-5.99 M-4.26 M-22.95 M-8.97 M -42.17 M Mittelzufluss aus Investitionstätigkeit -84 K-94 K-51 K-110 K-34 K9 000 -186 K Zahlungsströme aus der Finanzierungstätigkeit 283 K-10.25 M0000 0 Freier Cashflow -6.54 M-6.72 M-6.04 M-4.37 M-22.99 M-8.97 M -42.36 M

XBiotech Inc. - Common Stock

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

XBIT

Financials

XBiotech Inc. - Common Stock

Nachrichten

XBiotech shareholders approve board nominees and key proposals at annual meeting

XBiotech appoints Thomas Kündig and Craig Rademaker to board of directors